table of content
1 Study Coverage
1.1 Antibody Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Antibody Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Monoclonal Antibodies
1.2.3 Antibody-Drug Conjugates
1.2.4 Polyclonal Antibodies
1.3 Market by Application
1.3.1 Global Antibody Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Central Nervous System (CNS) Disorders
1.3.3 Cancers
1.3.4 Autoimmune Disorders
1.3.5 Cardiovascular Diseases
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antibody Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Antibody Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Antibody Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Antibody Drugs Sales by Region
2.4.1 Global Antibody Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Antibody Drugs by Region (2023-2028)
2.5 Global Antibody Drugs Revenue by Region
2.5.1 Global Antibody Drugs Revenue by Region (2017-2022)
2.5.2 Global Antibody Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Antibody Drugs Sales by Manufacturers
3.1.1 Global Top Antibody Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Antibody Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antibody Drugs in 2021
3.2 Global Antibody Drugs Revenue by Manufacturers
3.2.1 Global Antibody Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Antibody Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Antibody Drugs Revenue in 2021
3.3 Global Antibody Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Antibody Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Antibody Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Antibody Drugs Sales by Type
4.1.1 Global Antibody Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Antibody Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Antibody Drugs Sales Market Share by Type (2017-2028)
4.2 Global Antibody Drugs Revenue by Type
4.2.1 Global Antibody Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Antibody Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Antibody Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Antibody Drugs Price by Type
4.3.1 Global Antibody Drugs Price by Type (2017-2022)
4.3.2 Global Antibody Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Antibody Drugs Sales by Application
5.1.1 Global Antibody Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Antibody Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Antibody Drugs Sales Market Share by Application (2017-2028)
5.2 Global Antibody Drugs Revenue by Application
5.2.1 Global Antibody Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Antibody Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Antibody Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Antibody Drugs Price by Application
5.3.1 Global Antibody Drugs Price by Application (2017-2022)
5.3.2 Global Antibody Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Antibody Drugs Market Size by Type
6.1.1 North America Antibody Drugs Sales by Type (2017-2028)
6.1.2 North America Antibody Drugs Revenue by Type (2017-2028)
6.2 North America Antibody Drugs Market Size by Application
6.2.1 North America Antibody Drugs Sales by Application (2017-2028)
6.2.2 North America Antibody Drugs Revenue by Application (2017-2028)
6.3 North America Antibody Drugs Market Size by Country
6.3.1 North America Antibody Drugs Sales by Country (2017-2028)
6.3.2 North America Antibody Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Antibody Drugs Market Size by Type
7.1.1 Europe Antibody Drugs Sales by Type (2017-2028)
7.1.2 Europe Antibody Drugs Revenue by Type (2017-2028)
7.2 Europe Antibody Drugs Market Size by Application
7.2.1 Europe Antibody Drugs Sales by Application (2017-2028)
7.2.2 Europe Antibody Drugs Revenue by Application (2017-2028)
7.3 Europe Antibody Drugs Market Size by Country
7.3.1 Europe Antibody Drugs Sales by Country (2017-2028)
7.3.2 Europe Antibody Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Antibody Drugs Market Size by Type
8.1.1 Asia Pacific Antibody Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Antibody Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Antibody Drugs Market Size by Application
8.2.1 Asia Pacific Antibody Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Antibody Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Antibody Drugs Market Size by Region
8.3.1 Asia Pacific Antibody Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Antibody Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Antibody Drugs Market Size by Type
9.1.1 Latin America Antibody Drugs Sales by Type (2017-2028)
9.1.2 Latin America Antibody Drugs Revenue by Type (2017-2028)
9.2 Latin America Antibody Drugs Market Size by Application
9.2.1 Latin America Antibody Drugs Sales by Application (2017-2028)
9.2.2 Latin America Antibody Drugs Revenue by Application (2017-2028)
9.3 Latin America Antibody Drugs Market Size by Country
9.3.1 Latin America Antibody Drugs Sales by Country (2017-2028)
9.3.2 Latin America Antibody Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Antibody Drugs Market Size by Type
10.1.1 Middle East and Africa Antibody Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Antibody Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Antibody Drugs Market Size by Application
10.2.1 Middle East and Africa Antibody Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Antibody Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Antibody Drugs Market Size by Country
10.3.1 Middle East and Africa Antibody Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Antibody Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Overview
11.1.3 Novartis Antibody Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novartis Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Amgen
11.2.1 Amgen Corporation Information
11.2.2 Amgen Overview
11.2.3 Amgen Antibody Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Amgen Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Amgen Recent Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Corporation Information
11.3.2 Bristol-Myers Squibb Overview
11.3.3 Bristol-Myers Squibb Antibody Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bristol-Myers Squibb Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bristol-Myers Squibb Recent Developments
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Corporation Information
11.4.2 F. Hoffmann-La Roche Overview
11.4.3 F. Hoffmann-La Roche Antibody Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 F. Hoffmann-La Roche Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 F. Hoffmann-La Roche Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Corporation Information
11.5.2 Johnson & Johnson Overview
11.5.3 Johnson & Johnson Antibody Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Johnson & Johnson Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Johnson & Johnson Recent Developments
11.6 AbbVie
11.6.1 AbbVie Corporation Information
11.6.2 AbbVie Overview
11.6.3 AbbVie Antibody Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 AbbVie Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 AbbVie Recent Developments
11.7 Eli Lilly
11.7.1 Eli Lilly Corporation Information
11.7.2 Eli Lilly Overview
11.7.3 Eli Lilly Antibody Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Eli Lilly Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Eli Lilly Recent Developments
11.8 Pfizer
11.8.1 Pfizer Corporation Information
11.8.2 Pfizer Overview
11.8.3 Pfizer Antibody Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Pfizer Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Pfizer Recent Developments
11.9 Bayer
11.9.1 Bayer Corporation Information
11.9.2 Bayer Overview
11.9.3 Bayer Antibody Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Bayer Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Bayer Recent Developments
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Corporation Information
11.10.2 GlaxoSmithKline Overview
11.10.3 GlaxoSmithKline Antibody Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 GlaxoSmithKline Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 GlaxoSmithKline Recent Developments
11.11 Sanofi
11.11.1 Sanofi Corporation Information
11.11.2 Sanofi Overview
11.11.3 Sanofi Antibody Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Sanofi Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Sanofi Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Antibody Drugs Industry Chain Analysis
12.2 Antibody Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antibody Drugs Production Mode & Process
12.4 Antibody Drugs Sales and Marketing
12.4.1 Antibody Drugs Sales Channels
12.4.2 Antibody Drugs Distributors
12.5 Antibody Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Antibody Drugs Industry Trends
13.2 Antibody Drugs Market Drivers
13.3 Antibody Drugs Market Challenges
13.4 Antibody Drugs Market Restraints
14 Key Findings in The Global Antibody Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
